D. Collen and H. Lijnen, Basic and clinical aspects of fibrinolysis and thrombolysis, Blood, vol.78, pp.3114-3124, 1991.

A. Samson and R. Medcalf, Tissue-Type Plasminogen Activator: A Multifaceted Modulator of Neurotransmission and Synaptic Plasticity, Neuron, vol.50, issue.5, pp.673-678, 2006.
DOI : 10.1016/j.neuron.2006.04.013

M. Yepes, B. Roussel, C. Ali, and D. Vivien, Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic, Trends in Neurosciences, vol.32, issue.1, pp.48-55, 2009.
DOI : 10.1016/j.tins.2008.09.006

URL : https://hal.archives-ouvertes.fr/inserm-01296642

A. Krystosek and N. Seeds, Plasminogen activator release at the neuronal growth cone, Science, vol.213, issue.4515, pp.1532-1534, 1981.
DOI : 10.1126/science.7197054

N. Seeds, M. Basham, and S. Haffke, Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene, Proceedings of the National Academy of Sciences, vol.96, issue.24, pp.14118-14123, 1999.
DOI : 10.1073/pnas.96.24.14118

N. Mataga, N. Nagai, and T. Hensch, Permissive proteolytic activity for visual cortical plasticity, Proceedings of the National Academy of Sciences, vol.99, issue.11, pp.7717-7721, 2002.
DOI : 10.1073/pnas.102088899

D. Baranes, D. Lederfein, Y. Huang, M. Chen, C. Bailey et al., Tissue Plasminogen Activator Contributes to the Late Phase of LTP and to Synaptic Growth in the Hippocampal Mossy Fiber Pathway, Neuron, vol.21, issue.4, pp.813-825, 1998.
DOI : 10.1016/S0896-6273(00)80597-8

P. Calabresi, M. Napolitano, D. Centonze, G. Marfia, P. Gubellini et al., Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory, European Journal of Neuroscience, vol.54, issue.3, pp.1002-1012, 2000.
DOI : 10.1046/j.1460-9568.2000.00991.x

S. Tsirka, A. Gualandris, D. Amaral, and S. Strickland, Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator, Nature, vol.377, issue.6547, pp.340-344, 1995.
DOI : 10.1038/377340a0

O. Nicole, F. Docagne, C. Ali, I. Margaill, P. Carmeliet et al., The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling, Nat Med, vol.7, pp.59-64, 2001.

G. Liot, B. Roussel, N. Lebeurrier, K. Benchenane, J. Lopez-atalaya et al., Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity, Journal of Neurochemistry, vol.20, issue.5, pp.1458-1464, 2006.
DOI : 10.1016/j.expneurol.2004.05.032

URL : https://hal.archives-ouvertes.fr/inserm-01296667

R. Zhang, Z. Zhang, and M. Chopp, Thrombolysis With Tissue Plasminogen Activator Alters Adhesion Molecule Expression in the Ischemic Rat Brain ?? Editorial Comment, Stroke, vol.30, issue.3, pp.624-629, 1999.
DOI : 10.1161/01.STR.30.3.624

F. Correa, M. Gauberti, J. Parcq, R. Macrez, Y. Hommet et al., Tissue plasminogen activator prevents white matter damage following stroke, The Journal of Experimental Medicine, vol.122, issue.6, pp.1229-1242, 2011.
DOI : 10.1111/j.1471-4159.2007.04866.x

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173251

T. Matys and S. Strickland, Tissue plasminogen activator and NMDA receptor cleavage, Nature Medicine, vol.9, issue.4, pp.371-372, 2003.
DOI : 10.1038/nm0403-371

A. Samson, S. Nevin, D. Croucher, B. Niego, P. Daniel et al., Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function, Journal of Neurochemistry, vol.20, pp.1091-1101, 2008.
DOI : 10.1111/j.1471-4159.2008.05687.x

J. Chatterton, M. Awobuluyi, L. Premkumar, H. Takahashi, M. Talantova et al., Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits, Nature, vol.307, issue.6873, pp.793-798, 2002.
DOI : 10.1038/nature715

C. Low and K. Wee, New Insights into the Not-So-New NR3 Subunits of N-Methyl-D-aspartate Receptor: Localization, Structure, and Function, Molecular Pharmacology, vol.78, issue.1, pp.1-11, 2010.
DOI : 10.1124/mol.110.064006

S. Cull-candy and D. Leszkiewicz, Role of Distinct NMDA Receptor Subtypes at Central Synapses, Science Signaling, vol.2004, issue.255, p.16, 2004.
DOI : 10.1126/stke.2552004re16

G. Hardingham, Y. Fukunaga, and H. Bading, Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways, Nature Neuroscience, vol.5, pp.405-414, 2002.
DOI : 10.1038/nn835

F. Soriano and G. Hardingham, Compartmentalized NMDA receptor signalling to survival and death, The Journal of Physiology, vol.53, issue.2, pp.381-387, 2007.
DOI : 10.1113/jphysiol.2007.138875

Y. Liu, T. Wong, M. Aarts, A. Rooyakkers, L. Liu et al., NMDA Receptor Subunits Have Differential Roles in Mediating Excitotoxic Neuronal Death Both In Vitro and In Vivo, Journal of Neuroscience, vol.27, issue.11, pp.2846-2857, 2007.
DOI : 10.1523/JNEUROSCI.0116-07.2007

G. Kohr, NMDA receptor function: subunit composition versus spatial distribution, Cell and Tissue Research, vol.27, issue.Suppl 1, pp.439-446, 2006.
DOI : 10.1007/s00441-006-0273-6

A. Baron, A. Montagne, F. Casse, S. Launay, E. Maubert et al., NR2D-containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity, Cell Death and Differentiation, vol.23, issue.5, pp.860-871, 2010.
DOI : 10.1111/j.1471-4159.2006.03982.x

B. Feng, H. Tse, D. Skifter, R. Morley, D. Jane et al., Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid, British Journal of Pharmacology, vol.707, issue.3, pp.508-516, 2004.
DOI : 10.1038/sj.bjp.0705644

R. Morley, H. Tse, B. Feng, J. Miller, D. Monaghan et al., -Substituted Piperazine-2,3-dicarboxylic Acid Derivatives Acting as NMDA Receptor Antagonists, Journal of Medicinal Chemistry, vol.48, issue.7, pp.2627-2637, 2005.
DOI : 10.1021/jm0492498

URL : https://hal.archives-ouvertes.fr/hal-01259996

B. Costa, B. Feng, T. Tsintsadze, R. Morley, M. Irvine et al., N-Methyl-D-aspartate (NMDA) Receptor NR2 Subunit Selectivity of a Series of Novel Piperazine-2,3-dicarboxylate Derivatives: Preferential Blockade of Extrasynaptic NMDA Receptors in the Rat Hippocampal CA3-CA1 Synapse, Journal of Pharmacology and Experimental Therapeutics, vol.331, issue.2, pp.618-626, 2009.
DOI : 10.1124/jpet.109.156752

D. Wrighton, E. Baker, P. Chen, and D. Wyllie, oocytes, The Journal of Physiology, vol.117, issue.1, pp.211-225, 2008.
DOI : 10.1113/jphysiol.2007.143164

S. Kotermanski and J. Johnson, Mg2+ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine, Journal of Neuroscience, vol.29, issue.9, pp.2774-2779, 2009.
DOI : 10.1523/JNEUROSCI.3703-08.2009

K. Benchenane, V. Berezowski, C. Ali, M. Fernández-monreal, J. López-atalaya et al., Tissue-Type Plasminogen Activator Crosses the Intact Blood-Brain Barrier by Low-Density Lipoprotein Receptor-Related Protein-Mediated Transcytosis, Circulation, vol.111, issue.17, pp.2241-2250, 2005.
DOI : 10.1161/01.CIR.0000163542.48611.A2

URL : https://hal.archives-ouvertes.fr/hal-00542121

C. Orset, R. Macrez, A. Young, D. Panthou, E. Angles-cano et al., Mouse Model of In Situ Thromboembolic Stroke and Reperfusion, Stroke, vol.38, issue.10, pp.2771-2778, 2007.
DOI : 10.1161/STROKEAHA.107.487520

R. Macrez, L. Bezin, L. Mauff, B. Ali, C. Vivien et al., Functional Occurrence of the Interaction of Tissue Plasminogen Activator With the NR1 Subunit of N-Methyl-D-Aspartate Receptors During Stroke, Stroke, vol.41, issue.12, pp.2950-2955, 2010.
DOI : 10.1161/STROKEAHA.110.592360

R. Macrez, P. Obiang, M. Gauberti, B. Roussel, A. Baron et al., Antibodies Preventing the Interaction of Tissue-Type Plasminogen Activator With N-Methyl-D-Aspartate Receptors Reduce Stroke Damages and Extend the Therapeutic Window of Thrombolysis, Stroke, vol.42, issue.8, pp.2315-2337, 2011.
DOI : 10.1161/STROKEAHA.110.606293

. Jullienne, http://www.molecularneurodegeneration.com/content, Molecular Neurodegeneration, vol.61, issue.6, p.6868, 2011.

C. Thomas, A. Miller, and G. Westbrook, Synaptic and Extrasynaptic NMDA Receptor NR2 Subunits in Cultured Hippocampal Neurons, Journal of Neurophysiology, vol.95, issue.3, pp.1727-1734, 2006.
DOI : 10.1152/jn.00771.2005

G. Hardingham and H. Bading, Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders, Nature Reviews Neuroscience, vol.39, issue.10, pp.682-696, 2010.
DOI : 10.1038/nrn2911

S. Hrabetova, P. Serrano, N. Blace, H. Tse, D. Skifter et al., Distinct NMDA receptor subpopulations contribute to long-term potentiation and long-term depression induction, J Neurosci, vol.20, p.81, 2000.

N. Lozovaya, S. Grebenyuk, T. Tsintsadze, B. Feng, D. Monaghan et al., Extrasynaptic NR2B and NR2D subunits of NMDA receptors shape ???superslow??? afterburst EPSC in rat hippocampus, The Journal of Physiology, vol.16, issue.2, pp.451-463, 2004.
DOI : 10.1113/jphysiol.2004.063792

S. Harney, D. Jane, and R. Anwyl, Extrasynaptic NR2D-Containing NMDARs Are Recruited to the Synapse during LTP of NMDAR-EPSCs, Journal of Neuroscience, vol.28, issue.45, pp.11685-11694, 2008.
DOI : 10.1523/JNEUROSCI.3035-08.2008

D. Guard, T. Swartz, R. Ritter, G. Burns, and M. Covasa, NMDA NR2 receptors participate in CCK-induced reduction of food intake and hindbrain neuronal activation, Brain Research, vol.1266, pp.37-44, 2009.
DOI : 10.1016/j.brainres.2009.02.003

M. Hynd, H. Scott, and P. Dodd, Differential expression of N-methyl-d-aspartate receptor NR2 isoforms in Alzheimer's disease, Journal of Neurochemistry, vol.90, issue.4, pp.913-919, 2004.
DOI : 10.1111/j.1471-4159.2004.02548.x

K. Mckeage, Spotlight on Memantine in Moderate to Severe Alzheimer??s Disease???, Drugs & Aging, vol.23, issue.5, pp.177-179, 2010.
DOI : 10.2165/11204670-000000000-00000

H. Jeon, S. Han, K. Lim, K. Won, Y. Bae et al., Intracisternal Administration of NR2 Subunit Antagonists Attenuates the Nociceptive Behavior and p-p38 MAPK Expression Produced by Compression of the Trigeminal Nerve Root, Molecular Pain, vol.12, p.46, 2011.
DOI : 10.3171/jns.1999.90.1.0001

W. Hacke, M. Kaste, E. Bluhmki, M. Brozman, A. Davalos et al., Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke, Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke, pp.1317-1329, 2008.
DOI : 10.1056/NEJMoa0804656

L. Schmued, C. Stowers, A. Scallet, and L. Xu, Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons, Brain Research, vol.1035, issue.1, pp.24-31, 2005.
DOI : 10.1016/j.brainres.2004.11.054